BridgeBio Pharma, Inc. Annual Nonoperating Income (Expense) in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
BridgeBio Pharma, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2017 to 2023.
  • BridgeBio Pharma, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $27.5M.
  • BridgeBio Pharma, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $98.1M.
  • BridgeBio Pharma, Inc. annual Nonoperating Income (Expense) for 2023 was -$45.9M, a 267% decline from 2022.
  • BridgeBio Pharma, Inc. annual Nonoperating Income (Expense) for 2022 was $27.6M.
  • BridgeBio Pharma, Inc. annual Nonoperating Income (Expense) for 2021 was -$9.82M, a 68.3% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$45.9M -$73.4M -267% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-22
2022 $27.6M +$37.4M Jan 1, 2022 Dec 31, 2022 10-K 2024-02-22
2021 -$9.82M +$21.2M +68.3% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-22
2020 -$31M -$8.66M -38.8% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-23
2019 -$22.3M -$36.6M -257% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-25
2018 $14.2M +$14.2M +54550% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 $26K Jan 1, 2017 Dec 31, 2017 10-K 2020-03-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.